This bill proposes to classify 7 Hydroxymitragynine (7-OH) as a Schedule I controlled dangerous substance in New Jersey, effectively banning its sale, manufacture, and distribution. The bill amends Section 5 of P.L.1970, c.226 to include 7-OH in the list of substances deemed to have a high potential for abuse and no accepted medical use. It also establishes strict regulations for manufacturers and distributors, requiring them to issue immediate recalls for any products containing 7-OH and outlining the responsibilities of retailers in handling recalled products. Violations of these provisions will result in criminal charges, with penalties escalating for repeat offenses.

The intent behind this legislation is to address public health concerns associated with 7-OH, which is derived from the Mitragyna speciosa plant, commonly known as Kratom. The bill highlights the potential for abuse and addiction associated with 7-OH, particularly as products containing concentrated levels of the substance are readily available in various retail outlets. The FDA has warned about the risks posed by 7-OH, and this bill aims to align state law with federal recommendations to protect consumers from the dangers of this substance.

Statutes affected:
Introduced: 24:21-5